Elizabeta Nemeth

Author PubWeight™ 114.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2003 5.82
2 Immunoassay for human serum hepcidin. Blood 2008 5.32
3 Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005 3.10
4 The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 2007 2.99
5 Hepcidin and iron homeostasis. Biochim Biophys Acta 2012 2.96
6 Hepcidin in iron overload disorders. Blood 2005 2.88
7 Hepcidin and disorders of iron metabolism. Annu Rev Med 2011 2.67
8 Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 2009 2.61
9 Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 2007 2.52
10 Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 2007 2.51
11 Retracted The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 2008 2.25
12 Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis. Br J Haematol 2008 2.25
13 Proinflammatory state, hepcidin, and anemia in older persons. Blood 2010 2.19
14 Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest 2010 2.18
15 The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A 2005 2.10
16 Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 2005 2.08
17 In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2. Blood 2010 2.03
18 Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010 1.93
19 Iron sequestration and anemia of inflammation. Semin Hematol 2009 1.85
20 Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 2011 1.82
21 Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol 2006 1.81
22 Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 2007 1.78
23 Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta 2006 1.72
24 Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 2007 1.58
25 Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res 2008 1.57
26 The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 2009 1.51
27 Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood 2012 1.51
28 Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest 2011 1.49
29 Hepcidin and iron-loading anemias. Haematologica 2006 1.49
30 Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 2009 1.48
31 Novel urine hepcidin assay by mass spectrometry. Blood 2005 1.46
32 Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood 2004 1.44
33 Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006 1.43
34 Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab 2012 1.42
35 Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol Dis 2007 1.40
36 Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 2005 1.38
37 A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 2013 1.34
38 Manipulation of the hepcidin pathway for therapeutic purposes. Haematologica 2013 1.32
39 Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity (Silver Spring) 2009 1.28
40 Molecular and clinical correlates in iron overload associated with mutations in ferroportin. Haematologica 2006 1.23
41 Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica 2011 1.21
42 Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. Blood Cells Mol Dis 2007 1.20
43 Inhibition of hepcidin transcription by growth factors. Hepatology 2012 1.17
44 Rethinking iron regulation and assessment in iron deficiency, anemia of chronic disease, and obesity: introducing hepcidin. J Acad Nutr Diet 2012 1.10
45 Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 2013 1.07
46 Excess adiposity, inflammation, and iron-deficiency in female adolescents. J Am Diet Assoc 2009 1.07
47 Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol 2010 1.07
48 A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica 2010 1.07
49 Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood 2009 1.04
50 Iron metabolism: interactions with normal and disordered erythropoiesis. Cold Spring Harb Perspect Med 2012 1.01
51 Effects of plasma transfusion on hepcidin production in human congenital hypotransferrinemia. Haematologica 2007 1.01
52 Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab 2012 1.00
53 Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect Immun 2013 0.99
54 The hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disorders. Hematology Am Soc Hematol Educ Program 2011 0.99
55 New insights into iron regulation and erythropoiesis. Curr Opin Hematol 2015 0.98
56 Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload. J Hepatol 2008 0.97
57 Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity (Silver Spring) 2010 0.95
58 Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology 2005 0.95
59 Hepcidin is a key mediator of anemia of inflammation in Crohn's disease. J Crohns Colitis 2012 0.94
60 Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. J Hepatol 2009 0.92
61 High-throughput screening of small molecules identifies hepcidin antagonists. Mol Pharmacol 2013 0.91
62 Cellular catabolism of the iron-regulatory peptide hormone hepcidin. PLoS One 2013 0.87
63 Functional properties of human ferroportin, a cellular iron exporter reactive also with cobalt and zinc. Am J Physiol Cell Physiol 2013 0.86
64 Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. Chem Biol 2011 0.85
65 DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis. Blood 2006 0.85
66 Subcutaneous adipose tissue from obese and lean adults does not release hepcidin in vivo. ScientificWorldJournal 2011 0.84
67 Alpha 1-acid glycoprotein, hepcidin, C-reactive protein, and serum ferritin are correlated in anemic schoolchildren with Schistosoma haematobium. Am J Clin Nutr 2010 0.84
68 Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy. Haematologica 2013 0.81
69 Daily regulation of serum and urinary hepcidin is not influenced by submaximal cycling exercise in humans with normal iron metabolism. Eur J Appl Physiol 2009 0.81
70 Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome. Liver Int 2011 0.81
71 Design, synthesis, and characterization of cyclic analogues of the iron regulatory peptide hormone hepcidin. Biopolymers 2013 0.80
72 Total synthesis of human hepcidin through regioselective disulfide-bond formation by using the safety-catch cysteine protecting group 4,4'-dimethylsulfinylbenzhydryl. Angew Chem Int Ed Engl 2014 0.77
73 Intestinal ferroportin expression in pediatric Crohn's disease. Inflamm Bowel Dis 2011 0.77
74 Crosstalk between Erythropoiesis and Iron Metabolism. Adv Hematol 2010 0.76
75 Novel tools for the evaluation of iron metabolism. Haematologica 2010 0.75
76 IOD in rhinos--immunity group report: report from the Immunity, Genetics and Toxicology Working Group of the International Workshop on Iron Overload Disorder in Browsing Rhinoceros (February 2011). J Zoo Wildl Med 2012 0.75
77 Iron Metabolism in African American Women in the Second and Third Trimesters of High-Risk Pregnancies. J Obstet Gynecol Neonatal Nurs 2016 0.75
78 In a Mouse Model of Sepsis, Hepcidin Ablation Ameliorates Anemia More Effectively Than Iron and Erythropoietin Treatment. Shock 2017 0.75
79 Iron homeostasis and its disorders in mice and men: potential lessons for rhinos. J Zoo Wildl Med 2012 0.75